R

Rocket Pharmaceuticals
D

RCKT

3.14000
USD
-0.08
(-2.33%)
مغلق
حجم التداول
104,335
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
338,297,066
أصول ذات صلة
AAPL
AAPL
0.190
(0.09%)
213.950 USD
AMZN
AMZN
-0.780
(-0.34%)
231.450 USD
BA
BA
1.860
(0.80%)
233.160 USD
GOOG
GOOG
0.880
(0.46%)
194.090 USD
LMT
LMT
0.55
(0.13%)
421.26 USD
MSFT
MSFT
2.75
(0.54%)
513.73 USD
NOC
NOC
1.67
(0.29%)
569.91 USD
S
SPCE
-0.19000
(-4.41%)
4.11500 USD
TSLA
TSLA
10.99
(3.60%)
316.11 USD
المزيد
الأخبار المقالات

العنوان: Rocket Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.